Rituximab-based therapy and long-term control of autoimmune autonomic ganglionopathy

Arjun Gupta; Samar Harris; Steven Vernino; Harris V. Naina

doi:10.1007/s10286-015-0299-5

Rituximab-based therapy and long-term control of autoimmune autonomic ganglionopathy

Arjun Gupta, Samar Harris, Steven Vernino, Harris V. Naina

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Abstract

We present a patient with autoimmune autonomic ganglionopathy (AAG) who had persistently positive ganglionic nicotinic acetylcholine receptor antibody levels despite immunosuppressive therapy. Rituximab-based therapy for an incidental lymphoma was associated with prolonged symptomatic and serological control of AAG.

Original language	English (US)
Pages (from-to)	255-258
Number of pages	4
Journal	Clinical Autonomic Research
Volume	25
Issue number	4
DOIs	https://doi.org/10.1007/s10286-015-0299-5
State	Published - Aug 7 2015

Keywords

Autoimmune autonomic ganglionopathy
Management
Rituximab

ASJC Scopus subject areas

Clinical Neurology
Endocrine and Autonomic Systems

Access to Document

10.1007/s10286-015-0299-5

Cite this

@article{ef68e6517d9c4ec2a580d9e3be92a6bd,

title = "Rituximab-based therapy and long-term control of autoimmune autonomic ganglionopathy",

abstract = "We present a patient with autoimmune autonomic ganglionopathy (AAG) who had persistently positive ganglionic nicotinic acetylcholine receptor antibody levels despite immunosuppressive therapy. Rituximab-based therapy for an incidental lymphoma was associated with prolonged symptomatic and serological control of AAG.",

keywords = "Autoimmune autonomic ganglionopathy, Management, Rituximab",

author = "Arjun Gupta and Samar Harris and Steven Vernino and Naina, {Harris V.}",

year = "2015",

month = aug,

day = "7",

doi = "10.1007/s10286-015-0299-5",

language = "English (US)",

volume = "25",

pages = "255--258",

journal = "Clinical Autonomic Research",

issn = "0959-9851",

publisher = "D. Steinkopff-Verlag",

number = "4",

}

TY - JOUR

T1 - Rituximab-based therapy and long-term control of autoimmune autonomic ganglionopathy

AU - Gupta, Arjun

AU - Harris, Samar

AU - Vernino, Steven

AU - Naina, Harris V.

PY - 2015/8/7

Y1 - 2015/8/7

N2 - We present a patient with autoimmune autonomic ganglionopathy (AAG) who had persistently positive ganglionic nicotinic acetylcholine receptor antibody levels despite immunosuppressive therapy. Rituximab-based therapy for an incidental lymphoma was associated with prolonged symptomatic and serological control of AAG.

AB - We present a patient with autoimmune autonomic ganglionopathy (AAG) who had persistently positive ganglionic nicotinic acetylcholine receptor antibody levels despite immunosuppressive therapy. Rituximab-based therapy for an incidental lymphoma was associated with prolonged symptomatic and serological control of AAG.

KW - Autoimmune autonomic ganglionopathy

KW - Management

KW - Rituximab

UR - http://www.scopus.com/inward/record.url?scp=84941874949&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941874949&partnerID=8YFLogxK

U2 - 10.1007/s10286-015-0299-5

DO - 10.1007/s10286-015-0299-5

M3 - Article

C2 - 26245264

AN - SCOPUS:84941874949

SN - 0959-9851

VL - 25

SP - 255

EP - 258

JO - Clinical Autonomic Research

JF - Clinical Autonomic Research

IS - 4

ER -

Rituximab-based therapy and long-term control of autoimmune autonomic ganglionopathy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this